Versant Vantage II, L.P.
SEC CIK 1832235 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | 10% | 12.55M | — | — | 1 | 2021-12-23 | 2021-12-23 |
Most active insiders at IPSC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pfeiffenberger Brent | Pres, CEO, Dir | $47.7K | $14.6K |
| 2 | Cowan Chad | CSO | $49.4K | $2,731 |
| 3 | Russotti Gregory | See Remarks | — | $40.2K |
| 4 | Carr Douglas | SVP Fin, Ops | — | $28.6K |
Versant Vantage II, L.P. made no open-market trades at IPSC in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-28 | 2021-12-23 | IPSC | Century Therapeutics, Inc. | Versant Vantage II, L.P. | 10% | J - Other | $0.00 | -371.0K | 12.55M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations